From: Immunomodulation by lipid emulsions in pulmonary inflammation: a randomized controlled trial
Time, hours | ||||
---|---|---|---|---|
Group | 0 | 8 | 24 | |
Free fatty acid, μmol/l | ||||
AA | NaCl | 4.0 ± 0.6 | 3.3 ± 0.3 | 4.9 ± 1.0 |
SO | 4.0 ± 0.6 | 4.0 ± 0.7 | 4.6 ± 1.3 | |
FO | 4.3 ± 0.5 | 4.2 ± 0.8 | 5.0 ± 1.1 | |
EPA | NaCl | 0.6 ± 0.1 | 0.3 ± 0.0 | 0.4 ± 0.1 |
SO | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.7 ± 0.2 | |
FO | 0.7 ± 0.2 | 3.4 ± 0.8ab | 2.5 ± 0.4ab | |
DHA | NaCl | 0.8 ± 0.1 | 0.6± 0.2 | 0.9 ± 0.2 |
SO | 0.8 ± 0.1 | 0.9 ± 0.1 | 1.0 ± 0.2 | |
FO | 0.9 ± 0.1 | 2.2 ± 0.3a b | 3.0 ± 0.7a b | |
Sum | NaCl | 335.1 ± 50.2 | 336.8 ± 42.4 | 408.6 ± 74.3 |
SO | 346.0 ± 53.9 | 372.1 ± 42.1 | 366.5 ± 59.8 | |
FO | 377.4 ± 44.1 | 250.1 ± 29.8 | 348.3 ± 83.0 | |
Membrane fatty acid. % | ||||
AA | NaCl | 19.7 ± 0.5 | 19.2 ± 0.6 | 18.5 ± 0.5 |
SO | 19.4 ± 0.4 | 18.0 ± 0.8 | 20.0 ± 0.3 | |
FO | 19.4 ± 0.6 | 17.1 ± 0.8a | 17.4 ± 1.1a | |
EPA | NaCl | 0.2 ± 0.0 | 0.1 ± 0.0 | 0.1 ± 0.0 |
SO | 0.2 ± 0.0 | 0.1 ± 0.0 | 0.2 ± 0.0 | |
FO | 0.2 ± 0.0 | 1.9 ± 0.2a b | 1.3 ± 0.1a b | |
DHA | NaCl | 2.6 ± 0.1 | 2.4 ± 0.3 | 2.3 ± 0.2 |
SO | 2.9 ± 0.2 | 2.5 ± 0.3 | 2.8 ± 0.4 | |
FO | 3.1 ± 0.2 | 4.8 ± 0.2a b | 4.7 ± 0.4a b |